Free Trial

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Shares Down 5% - Here's What Happened

Shionogi & Co., Ltd. Unsponsored ADR logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Shares of Shionogi (OTCMKTS:SGIOY) fell about 5% to $9.60 on Wednesday, trading as low as $9.6017 with only ~6,325 shares changing hands — a 93% drop versus its average daily volume.
  • Analyst sentiment is mixed-to-negative: Goldman Sachs moved the stock to a "hold" while Zacks cut it to a "strong sell," leaving the consensus average rating at "Reduce".
  • Company fundamentals show a $16.38 billion market cap and a P/E of 12.67; Shionogi recently beat estimates with EPS $0.28 (vs. $0.19) and revenue $966.5M (vs. $848.4M), and reported a 41.82% net margin.
  • MarketBeat previews the top five stocks to own by May 1st.

Shares of Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report) were down 5% during trading on Wednesday . The stock traded as low as $9.6017 and last traded at $9.6026. Approximately 6,325 shares traded hands during trading, a decline of 93% from the average daily volume of 96,967 shares. The stock had previously closed at $10.1080.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on SGIOY. The Goldman Sachs Group raised shares of Shionogi & Co., Ltd. Unsponsored ADR to a "hold" rating in a research report on Wednesday, April 8th. Zacks Research lowered shares of Shionogi & Co., Ltd. Unsponsored ADR from a "hold" rating to a "strong sell" rating in a research report on Thursday, April 16th. One investment analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Shionogi & Co., Ltd. Unsponsored ADR currently has an average rating of "Reduce".

View Our Latest Analysis on SGIOY

Shionogi & Co., Ltd. Unsponsored ADR Stock Down 0.9%

The firm's 50-day moving average price is $10.98 and its 200-day moving average price is $9.62. The company has a market cap of $16.38 billion, a price-to-earnings ratio of 12.67, a price-to-earnings-growth ratio of 0.75 and a beta of 0.19. The company has a debt-to-equity ratio of 0.01, a current ratio of 5.84 and a quick ratio of 5.21.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report) last released its quarterly earnings data on Friday, January 30th. The company reported $0.28 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.19 by $0.09. The company had revenue of $966.53 million during the quarter, compared to analyst estimates of $848.42 million. Shionogi & Co., Ltd. Unsponsored ADR had a net margin of 41.82% and a return on equity of 13.70%. Sell-side analysts forecast that Shionogi & Co., Ltd. Unsponsored ADR will post 0.73 earnings per share for the current fiscal year.

Shionogi & Co., Ltd. Unsponsored ADR Company Profile

(Get Free Report)

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company's product portfolio spans both established and innovative therapies.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Shionogi & Co., Ltd. Unsponsored ADR Right Now?

Before you consider Shionogi & Co., Ltd. Unsponsored ADR, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Shionogi & Co., Ltd. Unsponsored ADR wasn't on the list.

While Shionogi & Co., Ltd. Unsponsored ADR currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2026 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines